| 000 | 01015 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518004226.0 | ||
| 264 | 0 | _c20190304 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2018.09.043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChoi, Woonyoung | |
| 245 | 0 | 0 |
_aERCC2 Mutation: The Marker for Chemosensitivity in Primary and Secondary Muscle-invasive Bladder Cancers. _h[electronic resource] |
| 260 |
_bEuropean urology _c02 2019 |
||
| 300 |
_a240-241 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aCisplatin |
| 650 | 0 | 4 | _aGenomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aUrinary Bladder Neoplasms |
| 650 | 0 | 4 |
_aXeroderma Pigmentosum Group D Protein _xgenetics |
| 700 | 1 | _aMcConkey, David J | |
| 773 | 0 |
_tEuropean urology _gvol. 75 _gno. 2 _gp. 240-241 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2018.09.043 _zAvailable from publisher's website |
| 999 |
_c28983788 _d28983788 |
||